Mr Raymond Brumbaugh, MD | |
3624 River Rd N, Keizer, OR 97303-5630 | |
(503) 561-5976 | |
(503) 561-4912 |
Full Name | Mr Raymond Brumbaugh |
---|---|
Gender | Male |
Speciality | |
Experience | Years |
Location | 3624 River Rd N, Keizer, Oregon |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1861500548 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208100000X | Physical Medicine & Rehabilitation | MD23948 (Oregon) | Primary |
Mailing Address | Practice Location Address |
---|---|
Mr Raymond Brumbaugh, MD 3624 River Rd N, Keizer, OR 97303-5630 Ph: (503) 561-5976 | Mr Raymond Brumbaugh, MD 3624 River Rd N, Keizer, OR 97303-5630 Ph: (503) 561-5976 |
News Archive
Weikang Bio-Technology Group Co., Inc., a leading developer, manufacturer and marketer of Traditional Chinese Medicine (TCM), Western prescription and OTC pharmaceuticals and other health and nutritional products in the People's Republic of China, today announced that the Company had filed an application to list its common stock on the NASDAQ Capital Market.
Centene Corporation and Health Net, Inc. announced that the Boards of Directors of both companies have unanimously approved a definitive agreement under which Centene will acquire all of the shares of Health Net in a cash and stock transaction valued at approximately $6.8 billion, including the assumption of approximately $500 million of debt.
The BIOMARGIN (BIOMArkers of Renal Graft INjuries in kidney allograft recipients) research project, coordinated by INSERM, has just received financing from the "health" seventh framework programme of the European Commission to the tune of 6 million euros for a four-year period.
In a new report, dozens of scientists, health practitioners and children's health advocates are calling for renewed attention to the growing evidence that many common and widely available chemicals endanger neurodevelopment in fetuses and children of all ages.
Ocera Therapeutics, Inc. presented an analysis of the prevalence of neurocognitive impairment in ambulatory cirrhotic patients. The data came from the screening period of the ASTUTE Study, an ongoing Phase 2b study evaluating the safety and efficacy of AST-120 (spherical carbon adsorbent) in the treatment of mild hepatic encephalopathy (MHE). The poster was presented yesterday at the annual meeting of the European Association for the Study of Liver (EASL) in Vienna, Austria. Efficacy and safety data from the ASTUTE study are expected in the summer of 2010.
› Verified 2 days ago
Erik D Blake, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 3624 River Rd N, Keizer, OR 97303 Phone: 503-561-5976 Fax: 503-561-4912 | |
Dr. Xiaoyue Li, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 3624 River Rd N, Keizer, OR 97303 Phone: 503-561-5976 | |
Mr. James David Hook, MD Physical Medicine & Rehabilitation Medicare: Medicare Enrolled Practice Location: 3624 River Rd N, Keizer, OR 97303 Phone: 503-561-5976 Fax: 503-561-4912 | |
Mr. John A French, MD Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 3624 River Rd N, Keizer, OR 97303 Phone: 503-561-5976 Fax: 503-561-4912 | |
Mr. Dung X Truong, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 3624 River Rd N, Keizer, OR 97303 Phone: 503-561-5976 Fax: 503-561-4912 |